Investigating trial design variability in trials of disease-modifying therapies in Parkinson's disease: a scoping review protocol.

This work will provide an overview of variation and emerging trends in trial design choices for disease-modifying trials of PD. Due to the nature of this study, there are no ethical or safety considerations. We plan to publish our findings in a peer-reviewed journal.